Evidence map›Paper›PMID 41258027›Full record

ArticleScientific reports2025

Disease-specific alterations of the enteric nervous system in precancerous colonic mucosa and their implications for mucin regulation.

Tetsuya Imura, Aya Miyagawa-Hayashino, Mizuki Honda, Akihito Harusato, Kazuhiro Katada, Eiichi Konishi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tetsuya ImuraDepartment of Surgical Pathology, Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji Kajii-Cho 465, Kamigyo-Ku, Kyoto, 602-8566, Japan. timura@koto.kpu-m.ac.jp.ORCID http://orcid.org/0000-0002-7184-2411
Aya Miyagawa-HayashinoDepartment of Pathology and Applied Biology, Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Mizuki HondaDepartment of Surgical Pathology, Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji Kajii-Cho 465, Kamigyo-Ku, Kyoto, 602-8566, Japan.
Akihito HarusatoDepartment of Gastroenterology, North Medical Center Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kazuhiro KatadaDepartment of Gastroenterology, North Medical Center Kyoto Prefectural University of Medicine, Kyoto, Japan.
Eiichi KonishiDepartment of Surgical Pathology, Graduate School of Medical Sciences, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji Kajii-Cho 465, Kamigyo-Ku, Kyoto, 602-8566, Japan.

Funding

the Ministry of Education, Culture, Sports, Science and Technology of Japan #18K06505
6 · The paper itself

Abstract

The dynamics of enteric glial cells (EGCs), the most prevalent cell type of the enteric nervous system (ENS), remain to be fully elucidated. Here, we analyzed the number and spatial distribution of Sox10 + mucosal EGCs in the human lower gastrointestinal tract. In the histologically normal mucosa, an average of 3.5 EGCs were present in each intercrypt region, with a higher concentration near the crypt base. Sex and anatomical location significantly influenced EGC numbers, while aging altered their intramucosal distribution. In both conventional adenomas (CAs) and sessile serrated lesions/polyps (SSLs), two main types of colonic precancerous lesions, EGC numbers were reduced by 80% compared with adjacent mucosa; however, the distribution of residual EGCs differed between these lesions. Neurite density analysis revealed that CAs exhibited overall depletion of ENS components, whereas SSLs showed selective loss of EGCs accompanied by increased vasoactive intestinal peptide (VIP) -positive neurites. In vitro co-culture experiments demonstrated that EGCs attenuate VIP- and its downstream effector cAMP-induced mucin gene expression in colonic epithelial cells via activating the PDK1-RSK pathway. These findings reveal differential alterations of the mucosal ENS between the two precancerous lesions, potentially creating unique microenvironments that contribute to their pathological features, such as mucin overproduction in SSLs.

Indexed as

ColonColonic NeoplasmsEnteric Nervous SystemIntestinal MucosaMucinsPrecancerous ConditionsAdenomaAdultAgedFemaleHumansMaleMiddle AgedNeuritesNeurogliaSOXE Transcription FactorsMucinsSOX10 protein, humanSOXE Transcription FactorsVasoactive Intestinal PeptideColorectal cancerEnteric gliaEnteric nervous systemSessile serrated lesions/polypsTumor microenvironment

Identifiers

PMID41258027
PMCPMC12630951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.